120 related articles for article (PubMed ID: 38008195)
1. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
[TBL] [Abstract][Full Text] [Related]
2. Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).
Homma A; Nakamura K; Matsuura K; Mizusawa J; Onimaru R; Fukuda H; Fujii M
Jpn J Clin Oncol; 2015 Jan; 45(1):119-22. PubMed ID: 25332419
[TBL] [Abstract][Full Text] [Related]
3. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.
Homma A; Onimaru R; Matsuura K; Shinomiya H; Sakashita T; Shiga K; Tachibana H; Nakamura K; Mizusawa J; Kitahara H; Eba J; Fukuda H; Fujii M; Hayashi R
Head Neck; 2018 Mar; 40(3):475-484. PubMed ID: 29130565
[TBL] [Abstract][Full Text] [Related]
4. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
6. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
7. Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.
Tsushima N; Kano S; Suzuki T; Idogawa H; Yoshida D; Yasuda K; Otsuka M; Aoyama H; Homma A
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):899-905. PubMed ID: 33866400
[TBL] [Abstract][Full Text] [Related]
8. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of superselective intra-arterial infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck.
Homma A; Sakashita T; Hatakeyama H; Kano S; Mizumachi T; Nakamaru Y; Yoshida D; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Sep; 135(9):950-4. PubMed ID: 25925195
[TBL] [Abstract][Full Text] [Related]
10. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
11. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
Kano S; Suzuki T; Yoshida D; Tsushima N; Hamada S; Yasuda K; Uchinami Y; Aoyama H; Homma A
Int J Clin Oncol; 2023 Sep; 28(9):1121-1128. PubMed ID: 37289379
[TBL] [Abstract][Full Text] [Related]
12. Ligation of the ethmoid arteries in superselective intra-arterial infusion of cisplatin for advanced maxillary sinus cancer fed by the ophthalmic artery.
Tamagawa K; Shinomiya H; Okada T; Tatehara S; Teshima M; Sasaki R; Nibu KI
Head Neck; 2023 May; 45(5):E16-E24. PubMed ID: 36891662
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.
Adachi M; Mitsudo K; Yamamoto N; Hagiwara S; Shigetomi T; Fujimoto Y; Lai SY; Tohnai I
Head Neck; 2013 Mar; 35(3):E89-93. PubMed ID: 21953943
[TBL] [Abstract][Full Text] [Related]
15. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
16. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer.
Balm AJ; Rasch CR; Schornagel JH; Hilgers FJ; Keus RB; Schultze-Kool L; Ackerstaff AH; Busschers W; Tan IB
Head Neck; 2004 Jun; 26(6):485-93. PubMed ID: 15162349
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
[TBL] [Abstract][Full Text] [Related]
18. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
[TBL] [Abstract][Full Text] [Related]
19. Impact of Radiation Dose on Treatment of Maxillary Cancer With Superselective Intra-arterial Cisplatin With Radiotherapy.
Konishi K; Kamiya M; Ohira K; Hirata M; Wakabayashi K; Ikenohira T; Kosugi T; Ushio T; Imai A; Mochizuki D; Yamaguchi Y; Tanahashi Y; Misawa K; Goshima S; Nakamura K
Anticancer Res; 2023 Jun; 43(6):2859-2864. PubMed ID: 37247919
[TBL] [Abstract][Full Text] [Related]
20. Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT).
Ashida H; Igarashi T; Nozawa Y; Munetomo Y; Higuchi T; Yamauchi H; Baba A; Abe Y; Shimura E; Kessoku H; Nishiya Y; Kojima H; Ojiri H
Head Face Med; 2021 Aug; 17(1):34. PubMed ID: 34399796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
